|
Market Closed -
Canadian Securities Exchange
14:24:44 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.9500 CAD | -47.22% |
|
-66.07% | -76.25% |
Company Valuation: ME Therapeutics Holdings Inc.
Data adjusted to current consolidation scope
| Fiscal Period: August | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 69.27 | 118.4 |
| Change | - | 70.86% |
| Enterprise Value (EV) 1 | 67.77 | 117 |
| Change | - | 72.67% |
| P/E | -51.7x | -93.2x |
| PBR | 46.9x | 78.7x |
| PEG | 0.6x | 4.8x |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | -49.4x | -94.1x |
| EV / EBIT | -49.4x | -91.7x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -0.0531 | -0.0429 |
| Distribution rate | - | - |
| Net sales | - | - |
| EBITDA 1 | -1.373 | -1.244 |
| EBIT 1 | -1.373 | -1.276 |
| Net income 1 | -1.295 | -1.193 |
| Net Debt 1 | -1.497 | -1.331 |
| Reference price 2 | 2.7500 | 4.0000 |
| Nbr of stocks (in thousands) | 25,189 | 29,589 |
| Announcement Date | 11/27/24 | 11/27/25 |
1CAD in Million2CAD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 38.67M | ||
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | ||
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | ||
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | ||
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | ||
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | ||
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | ||
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | ||
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | ||
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | ||
| Average | 26.11x | 26.57x | 15.32x | 0.32% | 37.24B | |
| Weighted average by Cap. | 25.97x | 25.01x | 15.48x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- METX Stock
- Valuation ME Therapeutics Holdings Inc.
Select your edition
All financial news and data tailored to specific country editions
















